MGRX News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

MG

Mkt Cap

$6.4M

Volume

258.27K

Next Earnings

November 13th

Loading chart

MG

MGRXMangoceuticals, Inc. Common Stock

MGRX

Pay with—

Available Balance0.00

MG

Mkt Cap

$7.1M

Volume

258.27K

Next Earnings

November 13th

Chart Financials Earnings News About Insider Filings

Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million TrancheMangoceuticals announced that its subsidiary MangoRx IP Holdings has secured $2.5 million in strategic investment from two investors for a 25% membership interest. The initial $1.75 million tranche has been received, with the remaining $750,000 due by November 28, 2026. The investment will fund commercialization of the company's antiviral intellectual property portfolio covering oral-surface administered preparations, with potential applications in poultry, livestock, and human oral-care markets valued at approximately $74.6 billion combined.GlobeNewswire Inc. · Oct 1, 2026

Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.Mangoceuticals filed a civil lawsuit against former technology consulting firm Clarity Ventures seeking over $73 million in damages for failure to deliver a fully functional, HIPAA-compliant ERP and eCommerce platform. Clarity has denied allegations and asserted counterclaims for unpaid invoices, which Mangoceuticals disputes. The company has since independently developed its own proprietary telehealth platform.GlobeNewswire Inc. · Mar 17, 2026

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or BirdsMangoceuticals, Inc. filed a PCT international patent application on February 26, 2026, to secure global patent protection for MGX-0024, an antiviral animal feed and drinking water additive. The filing follows recent clinical trial results showing zero respiratory-related mortality in 29,000 birds and prophylactic benefits against H5N1. The technology is already protected in the U.S. and has pending patents in major markets including the EU, Canada, China, India, Australia, and Japan.GlobeNewswire Inc. · Mar 6, 2026

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management ProgramsMangoceuticals launches weight-management programs MangoRx Direct and PeachesRx Direct, enabling patients to access FDA-approved GLP-1 medications like Zepbound and Wegovy through telehealth consultations at $99 per month.GlobeNewswire Inc. · Nov 14, 2025

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch DivisionMangoceuticals, a health and wellness company, has acquired the intellectual property and assets of Smokeless Technology Corp., a Canadian-based pouch innovation company. This acquisition will allow Mangoceuticals to expand into the growing oral pouch delivery market. The company has also appointed Tim Corkum, a former executive at Philip Morris, to lead its high-growth pouch division.GlobeNewswire Inc. · Apr 25, 2025

Azz Inc. COO acquires $21.2k in company stock By Investing.com - Investing.com AustraliaMangoceuticals, a health and wellness company, has appointed Dr. Douglas Christianson as the new Director of Medical Research and Product Innovation. Dr. Christianson will lead the company's product development efforts, particularly in areas like erectile dysfunction, hair growth, weight loss, and hormone replacement therapies.Investing.com · Jul 12, 2024

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyDallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss and hormone replacement therapies, is pleased to announce that it has received a Notice of Acceptance for Australian Patent Application No. 2020235666, which is the National Phase of International Application No. PCT/US2020/022903.GlobeNewswire Inc. · Jun 6, 2024

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont TechnologiesDallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, weight loss and hormone replacement therapies, is pleased to announce that it has received a Notice of Allowance for Japanese Patent Application No. 2021-545824, originally applied for by Intramont Technologies, Inc. (“Intramont”).GlobeNewswire Inc. · Jun 4, 2024

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing EffortsDallas, TX, May 23, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth, hormone replacement therapies and weight loss is excited to announce that it has engaged renown international performance marketing company, Crakmedia to champion the Company’s ongoing creative and digital marketing initiatives.GlobeNewswire Inc. · May 23, 2024

Spotting Penny Stocks Before They Explode, Top TipsHere's some tips for finding penny stocks before they shoot up in value The post Spotting Penny Stocks Before They Explode, Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.PennyStocks · May 22, 2024

to start trading

MG

MGRXMangoceuticals, Inc. Common Stock

MGRX

Pay with—

Available Balance0.00

Your PositionYou don't own any MGRX yet.

Related Tickers

Earnings